6 unknown. 6 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 6 |
| Phase 2 | 3 | Unknown 3 |
Follow Leishmaniasis: new trials by email Literature Review of Leishmaniasis trials Research Report on Leishmaniasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis Oral tofacitinib, Parenteral meglumine antimoniate - Cutaneous Leishmaniasis, American | Phase 2 / Phase 3 | Unknown | Hospital Universitário Professor Edgard Santos | 22 | 2023-10-01 | 2023-08-25 |
| Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly Miltefosine 50mg, Pentoxifylline 400mg, Liposomal Amphotericin B - Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous | Phase 2 / Phase 3 | Unknown | University of Brasilia | 100 | 2022-06-22 | 2023-09-15 |
| Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis Intralesional Sodium stibogluconate, Intralesional Cryotherapy, Intralesional Voriconazole - Leishmaniasis, Cutaneous | Phase 3 | Unknown | Zagazig University | 136 | 2022-01-01 | 2023-08-29 |
| Treatment of Mucosal Bolivian Leishmaniasis Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal amphotericin B - Mucosal Leishmaniasis | Phase 3 | Unknown | Fundacion Nacional de Dermatologia | 120 | 2021-04-01 | 2024-03-05 |
| Low Antimonial Dosage in American Mucosal Leishmaniasis Meglumine antimoniate - Mucosal Leishmaniasis, Mucocutaneous Leishmaniasis | Phase 2 / Phase 3 | Unknown | Oswaldo Cruz Foundation | 76 | 2008-10-01 | 2018-07-12 |
| Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia Miltefosine, Meglumine antimoniate - Cutaneous Leishmaniasis | Phase 3 | Unknown | Centro Internacional de Entrenamiento e Investigaciones Médicas | 150 | 2007-07-01 | 2010-02-17 |
Leishmaniasis, Mucocutaneous (4) · Leishmaniasis, Cutaneous (3)
Euglenozoa Infections (6) · Infections (6) · Parasitic Diseases (6) · Protozoan Infections (6) · Skin Diseases (6) · Skin Diseases, Infectious (6) · Skin Diseases, Parasitic (6) · Skin and Connective Tissue Diseases (6) · Vector Borne Diseases (6) · Leishmaniasis, Cutaneous (3)
Meglumine Antimoniate (2) · miltefosine (2) · Doxycycline (1) · Pentoxifylline (1) · Voriconazole (1) · liposomal amphotericin B (1) · tofacitinib (1)
Centro Internacional de Entrenamiento e Investigaciones Médicas (1) · Fundacion Nacional de Dermatologia (1) · Hospital Universitário Professor Edgard Santos (1) · Oswaldo Cruz Foundation (1) · University of Brasilia (1) · Zagazig University (1)
Brazil (3) · Bolivia (1) · Libya (1)
Armando O. Schubach, MD, PhD (1) · Hagar Nofal, Dr (1) · Luisa Consuelo Rubiano, MD, MSc (1)